Page last updated: 2024-09-05

sorafenib and granisetron

sorafenib has been researched along with granisetron in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(granisetron)
Trials
(granisetron)
Recent Studies (post-2010) (granisetron)
6,5207305,25159016

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)granisetron (IC50)
Solute carrier family 22 member 2Homo sapiens (human)4.3
DRattus norvegicus (Norway rat)3.8019
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)3.8019
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)3.8019
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)3.8019
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)3.8019
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)1.76
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)3.7702
Multidrug and toxin extrusion protein 1Homo sapiens (human)5
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)1.76

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for sorafenib and granisetron

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016